Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000063

Chief Financial Officer sold 3,141 shares at $34.71 ($109,024)

  • Chief Financial Officer acquired 8,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Exercise or conversion : show line 1 in the form 10b5-1 +8,500 58,139 D
2026-04-02 Sale : show line 2 in the form 10b5-1 −3,141 $34.71 $109,024 54,998 D
Open-market sales · 3,141 sh · avg $34.71 · $109,024

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-02 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −8,500 8,500 D
Loading xslF345X06/wk-form4_1775506133.xml…